Overview
MediCircle is a for-profit pharmacy that redistributes unopened, unused prescription medications from hospitals to patients at low or no cost. It collects sealed drugs (initially focusing on oral chemotherapies), recertifies them through licensed pharmacists, and ships them by mail after quality checks. Its platform catalogs each donation using GS1 barcodes and National Drug Codes (NDCs) to maintain a secure history and ensure compliance. Unlike many peers, MediCircle integrates with insurance formularies to negotiate discounts and does not charge patients, instead earning revenue by marking down the medication’s market value to insurers. The company also works with legislators to shape policy around pharmaceutical redistribution. Its goal is to reduce pharmaceutical waste, improve access to affordable medications, and create a scalable, compliant supply chain for medication redistribution.
Work here?Claim your company
Simplify's take
What believers are saying
- Brown updated October 12, 2026 says MediCircle has raised over $1.2 million.
- The model converts hospital waste into discounted specialty drug revenue without charging patients directly.
- Legislative work in Texas and Rhode Island expands reimbursement pathways and referral volume.
What critics are saying
- State-by-state redistribution rules still limit scale; one adverse ruling can freeze operations.
- Pharmacy recertification creates product-liability exposure; a contamination event can destroy trust overnight.
- Hospitals can bypass MediCircle with charity partners, killing supply and margins within 12 months.
What makes MediCircle unique
- MediCircle recertifies sealed oral chemotherapeutics, pairing pharmacists with GS1 and NDC tracking.
- Brown profile updated October 12, 2026 says MediCircle saves cancer patients up to $20,000.
- Jack Schaeffer and Eliza Sternlicht built a licensed pharmacy around medication redistribution lawmaking.
Help us improve and share your feedback! Did you find this helpful?